Please Wait...

Key Cardiovascular Mergers and Acquisitions

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership.  Over the last decade, Bioclinica has grown organically and through strategic acquisitions to enhance and strengthen its cardiac safety expertise, resources and offerings for clinical trial sponsors.

In 2004, Bioclinica (formerly Bio-Imaging Technologies) acquired Heartcore BV, a global provider of centralized cardiovascular imaging analysis specializing in various quantitative image analysis services. In 2013, Bioclinica merged with Core Lab Partners, adding renowned scientific expertise from Medifacts to its cardiovascular team, bolstering its centralized cardiovascular services portfolio and expanding its presence in Asia.  Most recently, in 2014, Bioclinica merged with SYNARC, supplementing an already strong cardiac safety program with additional scientific expertise and operations in the area of Echocardiography and cardiovascular imaging.

Bioclinica continues to strengthen its cardiovascular offerings, providing sponsors with world-class expertise, operations and technology to design, manage, and analyze cardiac safety data in support of new treatments.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

NJ Statewide Career & Internship Fair is Friday, April 28! Talk w @BioclinicaJobs Proj Mgmt, BD, CDM, IT. Details… https://t.co/27LdT00OEo
bioclinica (5 hours ago)
eHealth Solutions president Mukhtar Ahmed is speaking at #Phorum17 on Apr. 27 https://t.co/OaBPodxZBF https://t.co/VO6GKV0a8v
bioclinica (6 hours ago)
Global Head of Risk-Based Monitoring Kristin Mauri on #RBM essential capabilities. Read the blog here https://t.co/z3yUGZqOzH
bioclinica (11 hours ago)
Guest column by Nancy Bradish Myers & Anne McNickle on the White House deregulatory landscape @MedDeviceOnline… https://t.co/LlCJtAPpWz
bioclinica (11 hours ago)
Kicking off day 2 Clinical Trial Innov. Summit! Patient recruitment, RBM, technology-enabled #ClinicaTrials r hot t… https://t.co/IoynV539R9
bioclinica (13 hours ago)
Join us in Philly nxt wk at #Biomarkers & Immuno #Oncology World Congress! Happy to answer Qs in any of these areas https://t.co/fJ5mVAfQTe
bioclinica (Yesterday)

Latest Blogs: